Brooks Automation has declared that it has wrapped up the purchase of the Celigo Cell Cytometer, a product line of life sciences firm, Cyntellect located in San Diego, for roughly $9.2 million.

The Celigo Cell Cytometer product line had been launched in the market in the beginning of the fiscal year 2010. Due to its low cost, user friendliness and high output, the cell imaging system line has been widely accepted by a broad array of customers, including major academic institutions, biotechnology and pharmaceutical industries.

As per the acquisition deal, most of the workers of Cyntellect will be shifted to Brooks Automation’s facility located in Poway, California in order to carry out a smooth transformation of critical production, engineering, research and development capabilities, and field based support and sales staff.

Brooks Automation’s President and Chief Executive Officer, Dr. Steve Schwartz stated that the Celigo Cell Cytometer portfolio complements the company’s unique instrumentation products being utilized by the customers operating in the life sciences field. The line will be a part of the company’s high-throughput automated systems for testing, handling and study of compound and biological samples before and subsequent to their stacking in the company’s automated sample management systems, he said.

Schwartz further said that the Celigo cytometer line can be used to perform high-content and high-output fluorescence and brightfield cellular analysis and imaging with less sample manipulation. According to Cyntellect’s President and Chief Executive Officer, Saiid Zarrabian, the acquisition will accelerate the market expansion of the Celigo cytometer line.

Graphene oxide membranes have been receiving attention for their extremely powerful separation abilities and the ease at which it can be modified, allowing for membrane permittivity to be fine-tuned. These membranes show the potential to be used for water purification, ‘green’ gas purification and greenhouse gas capture.